LIF Form 4: Insider 10b5-1 Exercise at $11.18 and Sale at $100.24

Rhea-AI Filing Summary

Charles J. Prober, a director of Life360, Inc. (LIF), reported transactions on 09/15/2025 conducted under a Rule 10b5-1 trading plan. The Form 4 shows an acquisition of 7,930 shares via exercise of stock options at an $11.18 exercise price and a contemporaneous sale of 7,930 shares at $100.24 per share. After the transactions the reporting person’s direct beneficial ownership is reported as 105,456 shares in one line and 111,020 options-related shares in the derivative table; the filing also notes total holdings include 2,036 restricted stock units that convert to common stock upon vesting. The Form 4 states the 10b5-1 plan was adopted on March 14, 2025, and the option vesting schedule is described in the filing.

Positive

• Transactions executed under a documented Rule 10b5-1 trading plan adopted March 14, 2025, which supports compliance with insider trading rules
• Exercise price of $11.18 on the reported options is well below the sale price, indicating built-in option value realization

Negative

• Director sold 7,930 shares at $100.24, reducing direct beneficial ownership to 105,456 shares as reported
• Filing shows insider monetization of equity, which investors may view as decreased insider-held stock despite compliance

Insights

Securities Analyst

TL;DR: Routine insider exercise and sale under a pre-established 10b5-1 plan, showing option exercise at a low strike and immediate partial sale at market price.

The filing documents a mechanical exercise of 7,930 options at a stated $11.18 exercise price and a matched sale of 7,930 shares at $100.24, executed pursuant to a Rule 10b5-1 plan adopted March 14, 2025. This indicates the director used a pre-established plan to convert equity compensation into cash while retaining a significant residual stake comprised of common shares, vested options, and 2,036 restricted stock units. The filing is procedural and aligns with disclosed vesting mechanics; it does not present new operational or financial information about the company itself.

Corporate Governance Expert

TL;DR: Governance appears compliant: transactions were executed under a documented 10b5-1 plan and are disclosed on Form 4.

The report includes the required disclosure that the 10b5-1 plan was adopted when the reporting person was not aware of material nonpublic information, satisfying the affirmative defense statement in the filing. The Form 4 provides vesting details for the option and notes 2,036 restricted stock units included in holdings, which clarifies the nature of the director’s remaining equity exposure. From a governance perspective, the filing is complete and conforms to Section 16 reporting expectations.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Prober Charles J.

(Last) (First) (Middle)

C/O LIFE360, INC.

1900 SOUTH NORFOLK STREET, SUITE 310

(Street)

SAN MATEO CA 94403

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Life360, Inc. [ LIF ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
09/15/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common stock	09/15/2025		M(1)		7,930	A	$11.18	113,386(2)	D
Common stock	09/15/2025		S(1)		7,930	D	$100.24	105,456(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (right to buy)	$11.18	09/15/2025		M(1)			7,930	(3)	04/12/2028	Common stock	7,930	$0	111,020	D

Explanation of Responses:

1. The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2025. The Rule 10b5-1 trading plan is a written, pre-established trading plan that provides for the automatic sale of Company stock pursuant to predetermined criteria. The Reporting Person adopted the plan at a time when they were not aware of any material nonpublic information about the Company.

2. Includes 2,036 restricted stock units previously granted, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting.

3. The stock option vests and becomes exercisable as to 1/2 of the total number of shares on April 12, 2024 and thereafter vests and becomes exercisable as to 1/48th of the total number of shares in equal monthly installments, until such time as the option is 100% vested, subject to the continuing service of the Reporting Person on each vesting date.

Remarks:

	/s/ Jay Sood, Attorney-in-Fact	09/17/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Life360 director Charles J. Prober report on Form 4 (LIFX)?

The Form 4 reports that on 09/15/2025 Prober exercised 7,930 stock options at an $11.18 exercise price and sold 7,930 common shares at $100.24, under a Rule 10b5-1 plan.

Was the transaction part of a 10b5-1 trading plan for Life360 (LIF)?

Yes. The filing states the transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 14, 2025.

How many restricted stock units (RSUs) does the reporting person hold?

The filing discloses inclusion of 2,036 restricted stock units that represent contingent rights to receive one share each upon vesting.

What is the vesting schedule disclosed for the option?

The option vests 1/2 of the total on April 12, 2024 and thereafter vests in equal monthly installments of 1/48th until fully vested, subject to continuing service.

How many shares does the reporting person beneficially own after the reported transactions?

The Form 4 reports direct beneficial ownership figures of 113,386, 111,020 (derivative-related), and 105,456 in the various lines after the transactions; the filing notes holdings include the 2,036 RSUs.